These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33352233)

  • 41. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
    Kim S; Kwon SH; Kam TI; Panicker N; Karuppagounder SS; Lee S; Lee JH; Kim WR; Kook M; Foss CA; Shen C; Lee H; Kulkarni S; Pasricha PJ; Lee G; Pomper MG; Dawson VL; Dawson TM; Ko HS
    Neuron; 2019 Aug; 103(4):627-641.e7. PubMed ID: 31255487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
    Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
    Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
    Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
    Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
    Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
    Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
    Stoll AC; Sortwell CE
    Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease.
    Hong H; Wang Y; Menard M; Buckley JA; Zhou L; Volpicelli-Daley L; Standaert DG; Qin H; Benveniste EN
    J Neuroinflammation; 2024 Sep; 21(1):216. PubMed ID: 39218899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.
    Nuber S; Tadros D; Fields J; Overk CR; Ettle B; Kosberg K; Mante M; Rockenstein E; Trejo M; Masliah E
    Acta Neuropathol; 2014 Apr; 127(4):477-94. PubMed ID: 24509835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model.
    Sanchez-Guajardo V; Annibali A; Jensen PH; Romero-Ramos M
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):624-45. PubMed ID: 23771222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
    Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
    J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Spreading and Effects of Human Recombinant α-Synuclein Preformed Fibrils in the Cerebrospinal Fluid of Mice.
    Vandendriessche C; Bruggeman A; Foroozandeh J; Van Hoecke L; Dujardin P; Xie J; Van Imschoot G; Van Wonterghem E; Castelein J; Lucci C; De Groef L; Vandenbroucke RE
    eNeuro; 2024 Mar; 11(3):. PubMed ID: 38383588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.
    Creed RB; Goldberg MS
    Neuroscience; 2020 Jun; 437():64-75. PubMed ID: 32353461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
    Durante V; de Iure A; Loffredo V; Vaikath N; De Risi M; Paciotti S; Quiroga-Varela A; Chiasserini D; Mellone M; Mazzocchetti P; Calabrese V; Campanelli F; Mechelli A; Di Filippo M; Ghiglieri V; Picconi B; El-Agnaf OM; De Leonibus E; Gardoni F; Tozzi A; Calabresi P
    Brain; 2019 May; 142(5):1365-1385. PubMed ID: 30927362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
    Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice.
    Boyd SL; Kuhn NC; Patterson JR; Stoll AC; Zimmerman SA; Kolanowski MR; Neubecker JJ; Luk KC; Ramsson ES; Sortwell CE; Bernstein AI
    Toxicol Sci; 2023 Oct; 196(1):99-111. PubMed ID: 37607008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.